Global Dementia Treatment Market By Indication (Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia, Parkinson Disease Dementia, and Others), By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonist, MAO Inhibitors, Combination Drug, and Others), By Route of Administration (Oral, Transdermal Patch, and Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Dec 2024
- Report ID: 135745
- Number of Pages: 355
- Format:
-
keyboard_arrow_up
-
-
- Eisai Co. Ltd.
- Eli Lilly and Co
- Novartis AG
- Daiichi Sankyo Company Ltd.
- AbbVie Inc.
- Lundbeck A/S
- Biogen
- Cipla Inc.
- Sun Pharmaceutical Industries Ltd.
- Viatris Inc.
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible